ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.

Aparna Natarajan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.